P Blood Group and Related Antigens

  • Pascal Bailly
  • Jean-François Bouhours
Part of the Blood Cell Biochemistry book series (BLBI, volume 6)

Abstract

The human P blood group system was discovered by Landsteiner and Levine (1927) when these investigators found a new antigen present on the erythrocytes of about 80% of individuals, who were typed P(+), and absent on others, who were typed P(−). The system was defined by one antibody, anti-P, and one antigen, P. Then, Levine et al. (1951,1954) discovered a new antibody recognizing an antigen, termed Tja, present on erythrocytes of everyone but very rare individuals. By 1955, 15 people in the world, members of 9 families, were known to lack Tja on their red blood cells and contain anti-Tja in their serum. Sanger (1955) found that six out of six Tj(a-) individuals were P-negative, a proportion very improbable to occur by chance. Furthermore, anti-Tja sera were able to agglutinate P-negative as well as P-positive red cells, indicating that P-negative cells share a common antigen with P-positive cells. The P blood group system was redefined in order to include these new findings: original common P(+) and P(−) phenotypes became P1 and P2, respectively, and the new rare phenotype, previously called Tja−, was termed “little p.” A new antigen, common to P1 and P2 and lacking in p individuals, was termed P. The anti-Tja antisera were found to contain anti-P1 and anti-P antibodies.

Keywords

Blood Group Carbohydrate Chain Blood Group Antigen Relate Antigen Human Erythrocyte Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ando, S., Isobe, M.. and Nagai, Y., 1976, High performance preparative column chromatography of lipids using a new porous silica, Iatrobeads. I. Separation of molecular species of sphingoglycolipids, Biochim. Biophys. Acta 424: 98–105.PubMedGoogle Scholar
  2. Angström, J., Karlsson, H., Karlsson, K.-A., Larson, G., and Nilson, K., 1986, GalNAc13l-3-terminated glycosphingolipids of human erythrocytes, Arch. Biochem. Biophys. 251: 440–449.PubMedGoogle Scholar
  3. Bailly, P., Piller, F., Cartron, J.-P., Leroy, Y., and Fournet, B., 1986, Identification of UDP-galactose:lactose (lactosylceramide) a-4 and 13–3 galactosyltransferases in human kidney, Biochem. Biophys. Res. Commun. 141: 84–91.PubMedGoogle Scholar
  4. Bailly, P., Chevaleyre, J., Sondag, D., François-Gérard, F., Piquet, Y., Vezon, G., and Cartron, J.-P., 1987, Characterization of a murine monoclonal antibody specific for the human P, blood group antigen, Mol. Immunol. 24: 171–176.PubMedGoogle Scholar
  5. Bailly, P., Piller, F., Gillard, B., Veyrières, A., Marcus, D. M., and Cartron, J.-P., 1992, Biosynthesis of the blood group Pk and P, antigens by human kidney microsomes, Carbohydr. Res. 228: 277–287.PubMedGoogle Scholar
  6. Bell, C. A., Zwicker, H., and Rosenbaum, D. L., 1973, Paroxysmal cold hemoglobinuria (PCH) following mycoplasma infection: Anti-I specificity of the biphasic hemolysin, Transfusion 13: 138–141.PubMedGoogle Scholar
  7. Ben-Ismail, R., Carme, B., and Gentilini, M., 1979, Mise en évidence de substance P, ou P,-like dans Fasciola hepatica et Fasciola gigantica, Pathol. Biol. 27: 487–489.Google Scholar
  8. Ben-Ismail, R., Rouger, P., Carme, B., Gentilini, M., and Salmon, C., 1980, Comparative automated assay of anti-P, antibodies in acute hepatic distomiasis (fascioliasis) and in hydatidosis, Vox Sang. 38: 165–168.PubMedGoogle Scholar
  9. Bevan, B., Hammond, W., and Clarke, R. L., 1970, Anti-P, associated with liver fluke infection, Vox Sang. 18: 188–189.PubMedGoogle Scholar
  10. Boccardi, V., D’Annibali, S., DiNatale, G., Girelli, G., and Summonti, D., 1977, Mycoplasma pneumoniae infection complicated by paroxysmal cold hemoglobinuria with anti-P specificity of biphasic hemolysin, Blut 34: 211–214.Google Scholar
  11. Bock, K., Breimer, M. E., Brignole, A., Hansson, G. C., Karlsson, K.-A., Larson, G., Leffler, H., Samuelsson, B. O., Stromberg, N., Svanborg-Eden, C., and Thurin, J., 1985, Specificity of binding of a strain of uropathogenic Escherichia coli to Gala1–4Gal-containing glycosphingolipids, J. Biol. Chem. 260: 8545–8551.PubMedGoogle Scholar
  12. Bouhours, D., and Bouhours, J.-F., 1985, Developmental changes of the lipidic part of the neutral glycosphingolipids of the rat stomach, J. Biol. Chem. 260: 2172–2177.PubMedGoogle Scholar
  13. Bouhours, D., Bouhours, J.-F., Willem, C., Planus, E., and Blanchard, D., 1994, Overexpression of P, blood group antigen on red cells from a CDA-II patient, XXIIIrd Congr. Int. Soc. Blood Trans-fus., Amsterdam, Vox sang.67—S2(Abs): 118.Google Scholar
  14. Bouhours, D., Hansson, G. C., Angström, J., Jovall, P.-A., and Bouhours. J.-F., 1992, Two novel decaglycosylceramides with a blood group A-active tetrasaccharide repeat in the epithelial cells of the small intestine of inbred rats, J. Biol. Chem. 267: 18533–18540.PubMedGoogle Scholar
  15. Bouhours, J.-F., and Bouhours, D., 1984. Identification of free ceramide in human erythrocyte membrane, J. Lipid Res. 25: 613–618.PubMedGoogle Scholar
  16. Bouhours, J.-F., and Glickman, R. M., 1976, Rat intestinal glycolipids. II. Distribution and biosynthesis of glycolipids and ceramide in villus and crypt cells, Biochim. Biophys. Acta 441: 123–133.PubMedGoogle Scholar
  17. Bouhours, J.-F., Bouhours, D., and Delaunay, J., 1985, Abnormal fatty acid composition of erythrocyte glycosphingolipids in congenital dyserythropoietic anemia type II, J. Lipid Res. 26: 435–441.PubMedGoogle Scholar
  18. Breimer, M. E.. 1985, Chemical and immunological identification of the Forssman pentaglycosylceramide in human kidney, Glycoconjugate J. 2: 375–385.Google Scholar
  19. Breimer, M. E., and Jovall, P.-A., 1985, Structural characterization of a blood group A heptaglycosylceramide with globo-series structure, FEBS Lett. 179: 165–172.PubMedGoogle Scholar
  20. Breimer, M. E.. Cedergren, B., Karlsson, K.-A., Nilson, K., and Samuelsson, B. E., 1980, Glycolipid pattern of stomach tissue of a human with the rare blood group A,p, FEBS Lett. 118: 209–211.Google Scholar
  21. Breimer, M. E., Hansson, G. C., Karlsson, K.-A., and Leffler, H., 1981, Glycosphingolipids and the differentiation of intestinal epithelium, Exp. Cell Res. 135: 1–13.PubMedGoogle Scholar
  22. Brockhaus, M., Magnani. J. L., Blaszczyk, M., Steplewski, Z., Koprowski, H., Karlsson, K.-A., Larson, G., and Ginsburg, V., 1981, Monoclonal antibodies directed against the human Lek blood group antigen, J. Biol. Chem. 256: 13223–13225.PubMedGoogle Scholar
  23. Brown, K. E., Anderson, S. M., and Young, N. S., 1993, Erythrocyte P antigen: Cellular receptor for B19 parvovirus, Science 262: 114–117.PubMedGoogle Scholar
  24. Bruce, M., Watt. A., Gabra, G. S., Mitchell, R., Lakhesar, D., and Tippett, P., 1988, LKE red cell antigen and its relationship to P, and Pk: Serological study of a large family, Vox Sang. 55: 237–240.Google Scholar
  25. Buchbinder, L., 1935, Heterophile phenomena in immunology, Arch. Pathol. 19: 841–880.Google Scholar
  26. Burkhart, P. T., and Hsu, T. C. S., 1979, IgM cold-warm hemolysins in infectious mononucleosis, Transfusion 19: 535–538.Google Scholar
  27. Cameron, G. L., and Staveley, J. M., 1957, Blood group P substance in hydatid cyst fluids, Nature 179: 147–148.PubMedGoogle Scholar
  28. Carter. H. E., and Gaver, R. C., 1967, Improved reagent for trimethylsilylation of sphingoid bases, J. Lipid Res. 8: 391–395.Google Scholar
  29. Ciucanu, I., and Kerek, F., 1984. A simple and rapid method for permethylation of carbohydrates, Carbohvdr. Res. 131: 209–217.Google Scholar
  30. Clausen, H., Watanabe, K.. Kannagi, R., Levery, S. B., Nudelman, E., Arao-Tomono, Y., and Hakomori, S., 1984, Blood group A glycolipid (A’) with globo-series structure which is specific for blood group A, erythrocytes: One of the chemical bases for A, and A, distinction, Biochem. Biophys. Res. Commun. 124: 523–529.Google Scholar
  31. Clausen, H., Levery, S. B., Nudelman, E., Baldwin, M., and Hakomori, S.-L, 1986, Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes, Biochemistry 25: 7075–7085.PubMedGoogle Scholar
  32. Contreras, M., and Tippett, P., 1974, The Lu(a—b—) syndrome and an apparent upset of P, inheritance, Vox Sang. 27: 369–371.PubMedGoogle Scholar
  33. Cory, H. T., Yates, A. D.. Donald, A. S. R., Watkins. W. M., and Morgan, W. J. T., 1974, The nature of the human blood group P, determinant, Biochem. Biophys. Res. Commun. 61: 1289–1295.PubMedGoogle Scholar
  34. Cossait, Y. E., Cant, B., Field, A. M., and Widdows, D., 1975, Parvovirus-like particles in human serum, Lancet 1: 72–73.Google Scholar
  35. Cuatrecasas, P., 1973, Interaction of Vibrio cholerae enterotoxin with cell membranes, Biochemistry 12: 3547–3558.PubMedGoogle Scholar
  36. Dabrowski, J.. Hanfland, P., and Egge, H., 1982, Analysis of glycosphingolipids by high-resolution proton nuclear magnetic resonance spectroscopy, Methods Enzymol. 88: 69–86.Google Scholar
  37. Domon, B., and Costello. C. E., 1988, Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry, Biochemistry 27: 1534–1543.PubMedGoogle Scholar
  38. Donath, J., and Landsteiner, K., 1904, Uber paroxysmale häemoglobinurie, Muench. Med. Wochenschr. 51: 1590–1593.Google Scholar
  39. Egge, H., and Peter-Katalinic, J., 1987, Fast atom bombardment mass spectrometry for structural elucidation of glycoconjugates, Mass Spectrom. Rev. 6: 331–393.Google Scholar
  40. Engelfriet, C. P., Beeckers, D., von dem Borne, A. E. G. K., Reynierse, E., and van Loghem, J. J., 1971, Haemolysins probably recognizing the antigen p, Vox Sang. 23: 176–181.Google Scholar
  41. Feizi, T., Childs. R. A.. Watanabe, K., and Hakomori, S.-i., 1979, Three types of blood group I specificity among monoclonal anti-I autoantibodies revealed by analogues of a branched erythrocyte glycolipid, J. Exp. Med. 149: 975–980.PubMedGoogle Scholar
  42. Fellous, M., Gerbai, A., Nobillot, G., and Weils, J., 1977, Studies on the biosynthetic pathway of human P erythrocyte antigen using genetic complementation tests between fibroblasts from rare p and Pk phenotype donors, Vox Sang. 32: 262–268.PubMedGoogle Scholar
  43. Fellous, M., Cartron, J.-P., Wiels, J., and Tursz, T., 1985, A monoclonal antibody against a Burkitt lymphoma associated antigen has an anti-Pk red blood cell specificity, Br. J. Haematol. 60: 559–565.PubMedGoogle Scholar
  44. Fletcher, K. S., Bremer. E. G., and Schwarting, G. A., 1979, P blood group regulation of glycosphingolipid levels in human erythrocytes, J. Biol. Chem. 254: 11196–11198.Google Scholar
  45. Forssman, J., 1911, Die Herstellung hochwertiger spezischer Schafhamolysine ohne Verwendung von Schafblut. Ein Beitrag zur Lehre von heterologer Antikorperbildung, Biochem. Z. 37: 78–115.Google Scholar
  46. François-Gérard, C., Gerday, C., and Beeley, J. G., 1979, Turtle-dove ovomucoid, a glycoprotein proteinase inhibitor with P,-blood-group antigen activity, Biochem. J. 177: 679–695.PubMedGoogle Scholar
  47. Fukuda, M. N., Dell, A., Oates, J. E., Wu, P., Klock, J. C., and Fukuda, M., 1985, Structure of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-Nlactosaminylceramide and its significance in glycolipids of whole blood cells, J. Biol. Chem. 260: 1067–1082.PubMedGoogle Scholar
  48. Fukuda, M. N., Bothner, B., Scartezzini, P., and Dell, A., 1986, Isolation and characterization of polyN-acetyllactosaminylceramides accumulated in the erythrocytes of congenital dyserythropoietic anemia type II patients, Chem. Phys. Lipids 42: 185–197.PubMedGoogle Scholar
  49. Fukushima, K., Hirota, M., Terasaki, P. I., Wakisaka, A., Togashi, H., Chia, D., Suyama, N.. Fukushi, Y., Nudelman, E., and Hakomori, S.-i., 1984, Characterization of sialosylated Lewis` as a new tumor-associated antigen, Cancer Res. 44: 5279–5285.Google Scholar
  50. Gahmberg, C. G.. and Hakomori, S.-i., 1973, External labeling of cell surface galactose and galactosamine in glycolipid and glycoprotein of human erythrocytes, J. Biol. Chem. 248: 4311–4317.PubMedGoogle Scholar
  51. Gathuru. J. K., Miyoshi. I., and Naiki, M., 1991, In vitro immunization of rat spleen lymphocytes with Forssman glycosphingolipid antigen and the generation of a monoclonal antibody, J. Immunol. Methods 137: 95–102.Google Scholar
  52. Gaver. R. C., and Sweeley, C. C., 1965, Methods for methanolysis of sphingolipids and direct determination of long-chain bases by gas chromatography, J. Am. Oil Chem. Soc. 42: 294–298.Google Scholar
  53. Gooi, H. C., Feizi, T., Kapadia. A., Knowles, B. B., Solter, D., and Evans, J. M., 1981, Stagespecific embryonic antigen involves al-3 fucosylated type 2 blood group chains, Nature 292: 156–158.Google Scholar
  54. Graham, H. A., and Williams, A. N., 1980, A genetic model for the inheritance of the P, P, and Pk antigens, Immunol. Commun. 9: 191–201.PubMedGoogle Scholar
  55. Gross, S. K., and McCluer, R. H., 1980, High-performance liquid chromatographic analysis of neutral glycosphingolipids as their per-O-benzoyl derivatives, Anal. Biochem. 102: 429–433.PubMedGoogle Scholar
  56. Haataja, S., Tikkanen, K., Liukkonen, J., François-Gérard, C., and Finne, J., 1993, Characterization of a novel bacterial adhesion specificity of Streptococcus suis recognizing blood group P receptor oligosaccharides, J. Biol. Chem. 268: 4311–4317.PubMedGoogle Scholar
  57. Hakomori, S.-i., 1964, A rapid permethylation of glycolipids, and polysaccharides catalyzed by methylsulfinyl carbanion in dimethylsulfoxide, J. Biochem. 55: 205–208.PubMedGoogle Scholar
  58. Hakomori, S., and Kannagi, R., 1987, Carbohydrate antigens in higher animals, in Handbook of Experimental Immunology (D. M. Weir, L. A. Herzenberg, C. Blackwell, and L. A. Herzenberg, eds.) Vol. I, pp. 9.1–9. 39, Blackwell, Oxford.Google Scholar
  59. Hakomori, S., Wang, S. M., and Young, W. W., 1977, Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: Its possible identity with “A-like antigen” in human cancer, Proc. Natl. Acad. Sci. USA 74: 3023–3027.PubMedGoogle Scholar
  60. Hakomori, S.-i., Nudelman, E., Levery, S. B., and Kannagi, R., 1981, The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: A preliminary note, Biochem. Biophys. Res. Commun. 100: 1578–1586.PubMedGoogle Scholar
  61. Hansson, G. C., Karlsson, K.-A., Larson, G., McKibbin, J. M., Blaszczyk, M., Herlyn, M., Steplewski, Z., and Koprowski, H., 1983, Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. Characterization by antibody binding to glycosphingolipids in a chromatogram binding assay, J. Biol. Chem. 258: 4091–4097.PubMedGoogle Scholar
  62. Hansson, G. C., Bouhours, J.-F., and Angström, J., 1987, Characterization of neutral blood group B-active glycosphingolipids of rat gastric mucosa. A novel type of blood group active glycosphingolipid based on isogloboside, J. Biol. Chem. 262: 13135–13141.PubMedGoogle Scholar
  63. Hansson, G. C., Wazniowska, K., Rock, J. A., Ness. P. M., Kickler, T. S., Shirey, R. S., Niebyl, J. R., and Zopf, D., 1988, The glycosphingolipid composition of the placenta of a blood group P fetus delivered by a blood group P, woman and analysis of the anti-globoside antibodies found in maternal serum, Arch. Biochem. Biophys. 260: 168–176.Google Scholar
  64. Haselberger, C. G., and Schenkel-Brunner, H., 1982, Evidence for erythrocyte membrane glycoproteins being carriers of blood-group P, determinants, FEBS Lett. 149: 126–128.PubMedGoogle Scholar
  65. Heddle, N. M., 1989, Acute paroxysmal cold hemoglobinuria, Transfus. Med. Rev. 3: 219–229.PubMedGoogle Scholar
  66. Heiken, A., 1966, Observations on the blood group receptor P, and its development in children, Hereditas 56: 83–98.Google Scholar
  67. Holgersson, J., Bäcker, A. E., Breimer, M. E., Gustaysson, M. L., Jovall, P.-Â., Karlsson, H., Pimlott, W., and Samuelsson, B. E., 1992, The blood group B type-4 heptaglycosylceramide is a minor blood group B structure in human B kidneys in contrast to the corresponding A type-4 compound in A kidneys. Structural and in vitro biosynthetic studies, Biochim. Biophys. Acta 1180: 33–43.PubMedGoogle Scholar
  68. Iizuka, S., Chen, S.-H., and Yoshida, A., 1986, Studies on the human blood group P system: An existence of UDP-Gal:lactosylceramide al-4 galactosyltransferase in the small p type cells, Biochem. Biophys. Res. Commun. 137: 1187–1195.PubMedGoogle Scholar
  69. Ikin, E. W., Kay, H. E. M., Playfair, J. H. L., and Mourant, A. E., 1961, P, antigen in the human fetus, Nature 192: 883.Google Scholar
  70. Iseki, S., Masaki, S., and Levine, P., 1954, A remarkable family with the rare human isoantibody antiTj’ in four siblings; anti-Tj’ and habitual abortion, Nature 173: 1193–1194.PubMedGoogle Scholar
  71. Ishibashi, T., Kijimoto, S., and Makita, A., I974a, Biosynthesis of globoside and Forssman hapten from trihexosylceramide and properties of ß-N-acetyl-galactosaminyltransferase of guinea pig kidney, Biochim. Biophys. Acta 337: 92–106.Google Scholar
  72. Ishibashi, T., Ohkubo, 1., and Makita, A., 1974b, Solubilization and partial characterization of UDPN-acetylgalactosamine:globoside a-N-acetylgalactosaminyltransferase from dog spleen microsomes, Biochim. Biophys. Acta 484: 24–34.Google Scholar
  73. Issitt, C. H., Duckett, J. B., Osborne, B. M., Gut, J. B., and Beasley, J.. 1976, Another example of an antibody reacting optimally with p red cells, Br. J. Haematol. 34: 19–23.PubMedGoogle Scholar
  74. IUPAC—IUB Commission on Biochemical Nomenclature, 1977, The nomenclature of lipids; Recommendations (1976), Lipids 12: 455–468.Google Scholar
  75. Joseph, K. C., and Gockerman, J. P., 1975, Accumulation of glycolipids containing N-acetylglucosamine in erythrocyte stroma of patients with congenital dyserythropoietic anemia type II (HEM-PAS), Biochem. Biophys. Res. Commun. 65: 146–152.PubMedGoogle Scholar
  76. Joseph, K. C., Gockerman, J. P., and Alving, C. R., 1975, Abnormal lipid composition of the red cell membrane in congenital dyserythropoietic anemia type II (HEMPAS), J. Lab. Clin. Med. 85: 34–40.PubMedGoogle Scholar
  77. Källenius, G., Möllby, R., Svensson, S., Winberg, J., Lundblad, A., Svensson, S.. and Cedergren, B., 1980, The Pk antigen as receptor for the hemagglutinin of pyelonephritic Escherichia coli, FEMS Microbiol. Lett. 7: 297–302.Google Scholar
  78. Kannagi, R., Fukuda, M. N., and Hakomori, S.-i., 1982a, A new glycolipid antigen isolated from human erythrocyte membranes reacting with antibodies directed to globo-N-tetraosylceramide (globoside), J. Biol. Chem. 257: 4438–4442.PubMedGoogle Scholar
  79. Kannagi, R., Levine, P., Watanabe, K., and Hakomori, S.-i., 1982b, Recent studies of glycolipid and glycoprotein profiles and characterization of the major glycolipid antigen in gastric cancer of a patient of blood group genotype pp (Tja—) first studied in 1951, Cancer Res. 42: 5249–5254.PubMedGoogle Scholar
  80. Kannagi, R., Cochran, N. A., Ishigami, F., Hakomori, S.-i., Andrews, P. W., Knowles, B. B., and Solter, D., 1983a, Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globoseries ganglioside isolated from human teratocarcinoma cells, EMBO J. 2: 2355–2361.PubMedGoogle Scholar
  81. Kannagi, R., Levery, S. B., Ishigami, F., Hakomori, S.-i., Shevinsky, L. H., Knowles, B. B., and Softer, D., 1983b, New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3, J. Biol. Chem. 258: 8934–8942.PubMedGoogle Scholar
  82. Karlsson, K.-A., 1976, Microscale fingerprinting of blood-group fucolipids by mass spectrometry, in Glycolipid Methodology ( L. A. Witting, ed.), pp. 97–122, American Oil Chemists’ Society, Champaign, IL.Google Scholar
  83. Karlsson, K.-A., Leffler, H., and Samuelsson, B. E., 1974, Characterization of the Forssman glycolipid hapten of horse kidney by mass spectrometry, J. Biol. Chem. 249: 4819–4823.PubMedGoogle Scholar
  84. Karlsson, K.-A., Angström, J., Bergström, J., and Lanne, B., 1992, Microbial interaction with animal cell surface carbohydrates, APMIS Suppl. 27: 71–83.PubMedGoogle Scholar
  85. Karol, R. A., Kundu, S. K., and Marcus, D. M.. 1981, Immunochemical relationship between Forssman and globoside glycolipid antigens, Immunol. Commun. 10: 237–250.PubMedGoogle Scholar
  86. Karr, J. F., Nowicki, B. J., Truong, L. D., Hull, R. A., Moulds, J. J., and Hull, S. I., 1990, pap-2encoded fimbriae adhere to the P blood group-related glycosphingolipid stage-specific embryonic antigen 4 in the human kidney, Infect. Immun. 58: 4055–4062.Google Scholar
  87. Kijimito, S., Ishibashi, T., and Makita, A., 1974, Biosynthesis of Forssman hapten from globoside by a-N-acetylgalactosaminyltransferase from guinea pig tissues, Biochem. Biophys. Res. Commun. 57: 177–184.Google Scholar
  88. Kijimoto-Ochiai, S.. Naiki, M., and Makita, A., 1977, Defects of glycosyltransferase activities in human fibroblasts of P“ and p blood group phenotypes, Proc. Natl. Acad. Sci. USA 74: 5407–5410.PubMedGoogle Scholar
  89. Kijimoto-Ochiai, S., Yokosawa, N., and Makita, A., 1980, Mechanism for the biosynthesis of Forssman glycolipid from trihexosylceramide, J. Biol. Chem. 255: 9037–9040.PubMedGoogle Scholar
  90. Kortekangas, A. E., Noades, J., Tippett, P., Sanger, R., and Race, R. R., 1959, A second family with the red cell antigen Pk, Vox Sang. 4: 337–349.PubMedGoogle Scholar
  91. Kortekangas, A. E., Kaarsalo, E., Melanin, L., Tippett, P., Gavin, J., Noades, J., Sanger, R., and Race, R. R., 1965, The red cell antigen P“ and its relationship to the P system: The evidence of three more P” families, Vox Sang. 10: 385–404.PubMedGoogle Scholar
  92. Koscielak, J., Miller-Podraza, H., Krause, R., and Cedergren, B., 1976, Glycolipid composition of blood group p erythrocytes. FEBS Lett. 66: 250–253.PubMedGoogle Scholar
  93. Kundu, S. K., Steane, S. M., Bloom, J. E. C., and Marcus, D. M.. 1978, Abnormal glycolipid composition of erythrocytes with a weak P antigen, Vox Sang. 35: 160–167.PubMedGoogle Scholar
  94. Kundu, S. K., Evans, A., Rizvi, J., Glidden. H., and Marcus, D. M., 1980. A new Pk phenotype in the P blood group system, J. Immunogenet. 7: 431–439.PubMedGoogle Scholar
  95. Lampio, A.. 1988. Exposure of major glycolipids in human Pk and p erythrocytes, Glycoconjugate J. 5: 513–520.Google Scholar
  96. Lampio, A., Finne, J., Homer, D., and Gahmberg, C. G., 1984, Exposure of the major human red-cell glycolipid, globoside. to galactose oxidase, Eur. J. Biochem. 145: 77–82.PubMedGoogle Scholar
  97. Lampio, A., Airaksinen. A., and Maaheimo, H., 1993, UDP-galactose: lactosylceramide a-galactosyltransferase activity in human placenta, Glycoconjugate J. 10: 165–169.Google Scholar
  98. Landsteiner, K., and Levine, P., 1927, Further observations on individual differences of human blood, Proc. Soc. Exp. Biol. N.Y. 24: 941–942.Google Scholar
  99. Larson, G., Karlsson, H., Hansson, G. C., and Pimlott, W., 1987, Application of a simple methylation procedure for the analyses of glycosphingolipids, Carbohydr. Res. 161: 281–290.PubMedGoogle Scholar
  100. Leffler, H., and Svanborg-Eden, C., 1980, Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes, FEMS Micobiol. Lett. 8: 127–134.Google Scholar
  101. Levery, S. B., and Hakomori. S.-i., 1987, Microscale methylation analysis of glycolipids using capillary gas chromatography—chemical ionization mass fragmentography with selected ion monitoring, Methods Enzymol. 138: 13–25.PubMedGoogle Scholar
  102. Levine, P., and Koch, E. A., 1954, The rare human isoagglutinin anti-Tja and habitual abortion, Science 120: 239–241.PubMedGoogle Scholar
  103. Levine, P., Bobbit, O. B., Waller, R. K., and Kuhmichel, A., 1951, Iso-immunization by a new blood factor in tumor cells, Proc. Soc. Exp. Biol. N.Y. 77: 403–405.Google Scholar
  104. Levine, P., Robinson, E. A., Pryer, B., and Michel, 0., 1954, Anti-Tja in a second pair of US sibs with observations on the original sibs, Vox Sang. 4: 143–148.Google Scholar
  105. Levine, P., Celano, M. J., and Falkowski, F., 1963, The specificity of the antibody in paroxysmal cold hemoglobinuria (PCH), Transfusion 3: 278–280.PubMedGoogle Scholar
  106. Lewis, M., and 32 others, 1990, Blood group terminology (1990). From the ISBT Working Party on terminology for red cell surface antigens, Vox Sang. 58: 152–169.Google Scholar
  107. Lindberg, A. A., Brown, E., Strömberg, N., Westling-Ryd, M., Schutz, J., and Karlsson, K.-A., 1987, Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1, J. Biol. Chem. 262: 1779–1785.PubMedGoogle Scholar
  108. Lindberg, B., 1972, Methylation analysis of polysaccharides, Methods Enzymol. 28: 178–195.Google Scholar
  109. Lindstedt, R., Larson, G.. Falk, P., Jodal, U., Leffler, H., and Svanborg, C.. 1991, The receptor repertoire defines the host range for attaching Escherichia coli strains that recognize globo-A, Infect. Immun. 59: 1086–1092.PubMedGoogle Scholar
  110. Lindstrom, K., von dem Borne, A. E. G. K., Breimer, M. E., Cedergren, B., Okubo, Y., Rydberg, L., Teneberg, S., and Samuelsson, B. E., 1992, Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group-p women. Evidence for placenta being the primary target for anti-Tj(a)-antibodies, Glycoconjugate J. 9: 325–329.Google Scholar
  111. Lopez, M., Cartron, J., Cartron, J.-P., Mariotti, M., Bony, V., Salmon. C., and Levene, C., 1983, Cytotoxicity of anti-PPP antibodies and possible relationship with early abortions of p mothers, Clin. Immunol. Immunopathol. 28: 296–303.Google Scholar
  112. Mallette, M. F., and Rush, R. L.. 1972, Isolation and composition of Forssman hapten from sheep erythrocytes, Immunochemistry 9: 809–820.PubMedGoogle Scholar
  113. Mandrell, R. E., 1992, Further antigenic similarities of Neisseria gonorrhoeae lipooligosaccharides and human glycosphingolipids, Infect. Immun. 60: 3017–3020.PubMedGoogle Scholar
  114. Marcus, D. M., 1971, Isolation of a substance with blood-group P, activity from human erythrocyte membrane, Transplantation 11: 16–18.Google Scholar
  115. Marcus, D. M., Naiki, M.. and Kundu, S., 1976, Abnormalities in the glycosphingolipid content of human P“ and p erythrocytes, Proc. Nat!. Acad. Sci. USA 73: 3263–3267.PubMedGoogle Scholar
  116. Marcus, D. M., Kundu, S. K., and Suzuki, A., 1981, The P blood group system: Recent progress in immunochemistry and genetics, Semin. Hematol. 18: 63–71.PubMedGoogle Scholar
  117. Matson, G. A., Swanson, J., Noades, J., Sanger, R., and Race, R. R.. 1959. A “new” antigen and antibody belonging to the P blood group system, Am. J. Hum. Genet. 11: 26–34.PubMedGoogle Scholar
  118. Messeter, L., and Johnson, U., 1990, Preface to the Proceedings on Monoclonal Antibodies Against Human Red Blood Cells and Related Antigens, J. Immunogenet. 17: 213–215.Google Scholar
  119. Metaxas, M. N., Metaxas-Buehler, M., and Tippett, P., 1975, A “new” antibody in the P blood group system. Commun. 14th Congr. Int. Soc. Blood Transfus., Helsinki, p. 95.Google Scholar
  120. Moller, B., and Jorgensen. J., 1988, Phenotype frequency of LKE in the Danish population, Hum. Hered. 38: 375–377.PubMedGoogle Scholar
  121. Morgan, W. T. J.. and Watkins, W. M., 1964, Blood group P, substance: (I) Chemical properties, Proc. 9th Congr. Int. Soc. Blood Transfus. Mexico, 1962, pp. 225–229.Google Scholar
  122. Naiki, M., and Marcus, D. M., 1974, Human erythrocyte P and P“ blood group antigens: Identification as glycosphingolipids, Biochem. Biophys. Res. Commun. 60: 1105–1111.PubMedGoogle Scholar
  123. Naiki, M., and Marcus, D. M., 1975, An immunochemical study of the human blood group P,, P, P“ glycosphingolipid antigens, Biochemistry 14: 4837–4841.PubMedGoogle Scholar
  124. Naiki, M., and Marcus, D. M., 1977, Binding of N-acetylgalactosamine-containing compounds by human 1gM paraprotein. J. Immunol. 119: 537–539.PubMedGoogle Scholar
  125. Naiki, M., Fong, J., Ledeen, R., and Marcus, D. M., 1975, Structure of the human erythrocyte blood group P, glycosphingolipid, Biochemistry 14: 4831–4837.PubMedGoogle Scholar
  126. Niemann, H.. Watanabe, K., Hakomori, S.-i., Childs, R. A., and Feizi, T., 1978, Blood group i and I activities of “lacto-N-norhexaosylceramide” and its analogues: The structural requirements for i-specificities, Biochem. Biophys. Res. Commun. 81: 1286–1293.PubMedGoogle Scholar
  127. Nudelman, E., Kannagi, R., Hakomori, S., Parsons, M., Lipinski, M., Wiels, J., Fellous, M., and Tursz, T., 1983, A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science 220: 509–511.PubMedGoogle Scholar
  128. Prokop, O., and Schlesinger, D., 1965, Über das Vorkommen von P,- Blutgruppen-substanz bei einigen Metazoen. insbesondere Ascaris suum and Lumbricus terrestris, Z. Immunitaetsforsh. 129: 344–353.Google Scholar
  129. Race, R. R., and Sanger, R., 1975, The P blood groups, in Blood Groups in Man, 6th ed., pp. 139–177, Blackwell, Oxford.Google Scholar
  130. Radermecker, M., Bruwier, M., François, C., Brocteur, J., Salmon, J., André, A., and van Cauwen-Google Scholar
  131. Berge, H. 1975, Anti-P, activity in pigeon breeders’ serum, Clin. Exp. Immunol. 22: 546–549.Google Scholar
  132. Saito, T., and Hakomori. S., 1971, Quantitative isolation of total glycosphingolipids from animal cells, J. Lipid Res. 12: 257–259.PubMedGoogle Scholar
  133. Sanger, R., 1955, An association between the P and Jay systems of blood groups, Nature 176: 1163–1164.PubMedGoogle Scholar
  134. Schwarting, G. A., Marcus, D. M.. and Metaxas, M., 1977, Identification of sialosylparagloboside as the erythrocyte receptor for an “anti-p” antibody, Vox Sang. 32: 257–261.PubMedGoogle Scholar
  135. Schwarting, G. A., Kundu, S. K., and Marcus, D. M., 1979, Reaction of antibodies that cause paroxysmal cold hemoglobinuria (PCH) with globoside and Forssman glycosphingolipids, Blood 53: 186–192.PubMedGoogle Scholar
  136. Shechter, Y., Timor-Tritsch, I. E., Lewit, N., Sela, R., and Levene, C., 1987, Early treatment by plasmapheresis in a woman with multiple abortions and the rare blood group p. Vox Sang. 53: 135–138.PubMedGoogle Scholar
  137. Shevinsky, L. H., Knowles, B. B., Damjanov, I., and Solter, D., 1982, Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells, Cell 30: 697–705.PubMedGoogle Scholar
  138. Siddiqui, B., and Hakomori, S., 1971, A revised structure for the Forssmann glycolipid hapten, J. Biol. Chem. 246: 5766–5769.PubMedGoogle Scholar
  139. Siddiqui, B., and Hakomori, S., 1973, A ceramide tetrasaccharide of human erythrocyte membrane reacting with anti-type XIV pneumococcal polysaccharide antiserum, Biochim. Biophys. Acta 330: 147–155.PubMedGoogle Scholar
  140. Söderström, T., Enskog, A., Samuelsson, B. E., and Cedergren, B., 1985, Immunoglobulin subclass (IgG3) restriction of anti-P and anti-Pk antibodies in patients of the rare p blood group, J. Immunol. 134: 1–3.PubMedGoogle Scholar
  141. Sonnenberg, A., van Balen, P., Hengeveld, T., Kolvenbag, G. J. C. M., van Hoeven, R. P., and Higers, J., 1986, Monoclonal antibodies detecting different epitopes on the Forssman glycolipid hapten, J. Immunol. 137: 1264–1269.PubMedGoogle Scholar
  142. Staveley, J. M., and Cameron, G. L., 1958, The inhibiting action of hydatid cyst fluid on anti-Tj’ sera, Vox Sang. 3: 114–118.PubMedGoogle Scholar
  143. Stellner, K., Saito, H., and Hakomori, S.-i., 1973, Determination of aminosugar linkages in glycolipids by methylation. Aminosugar linkages of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen, Arch. Biochem. Biophys. 155: 464–472.PubMedGoogle Scholar
  144. Stoffyn, A., Stoffyn, P., and Hauser, G., 1974, Structure of trihexosylceramide biosynthesized in vitro by rat kidney galactosyltransferase, Biochim. Biophys. Acta 360: 174–178.PubMedGoogle Scholar
  145. Stromberg, N., Marklund, B.-I., Lund, B., Ilver, D., Hamers, A., Gaastra, W., Karlsson, K.-A., and Normark, S., 1990, Host-specificity of uropathogenic E. coli depends on differences in binding specificity to Gala1–4Gal-containing isoreceptors, EMBO J. 9: 2001–2010.PubMedGoogle Scholar
  146. Suzuki, A., Kundu, S. K., and Marcus, D. M., 1980, An improved technique for the separation of neutral glycosphingolipids by high-performance liquid chromatography, J. Lipid Res. 21: 473–477.PubMedGoogle Scholar
  147. Takeya, A., Hosomi, O., Shimoda, N., and Yasawa, S., 1992, Biosynthesis of the blood group P antigen-like GaINA42I–3Ga1131–4G1cNAc/Glc structure: A novel N-acetylgalactosaminyltransferase in human blood plasma, J. Biochem. 112: 389–395.PubMedGoogle Scholar
  148. Tanaka, N., and Leduc, E. H., 1956, Study on cellular distribution of Forssman antigen in various species, J. Immunol. 77: 198–212.PubMedGoogle Scholar
  149. Taniguchi, N., and Makita, A., 1984, Purification and characterization of UDP-N-acetylgalactosamine:globotriaosylceramide ß-3-N-acetylgalactosaminyltransferase, a synthase of human blood group P antigen, from canine spleen, J. Biol. Chem. 259: 5637–5642.PubMedGoogle Scholar
  150. Taniguchi, N., Yokosawa, N., Narita, M., Mitsuyama, T., and Makita, A., 1981, Expression of Forssman antigen synthesis and degradation in human lung cancer, J. Natl. Cancer Inst. 67: 577–583.PubMedGoogle Scholar
  151. Taniguchi, N., Yanagisawa, K., Makita, A., and Naiki, M., 1985a, Purification and properties of rat liver globotriaosylceramide synthase, UDP-galactose: lactosylceramide al-4- galactosyltransferase, J. Biol. Chem. 260: 4908–4913.PubMedGoogle Scholar
  152. Taniguchi, N., Yanagisawa, K., Makita, A., Mizuno, F., and Osato, T., I985b, Globoside and Forssman synthases in human lymphocytes exposed to Epstein-Barr virus and mitogens, J. Natl. Cancer Inst. 74: 563–568.Google Scholar
  153. Thorn, J. J., Levery, S. B., Salyan, M. E. K., Stroud, M. R., Cedergren, B., Nilsson, B., Hakomori, S.-i., and Clausen, H., 1992. Structural characterization of x2 glycosphingolipid, its extended form, and its sialosyl derivatives: Accumulation associated with the rare blood group p phenotype, Biochemistry 31: 6509–6517.PubMedGoogle Scholar
  154. Tippett, P., 1986, Contributions of monoclonal antibodies to understanding one new and some old blood group systems, in Red Cell Antigens and Antibodies (G. Garratty, ed,) pp. 83–98, American Association of Blood Banks, Arlington. VA.Google Scholar
  155. Tippett, P., Andrews, P. W., Knowles, B. B., Solter, D., and Goodfellow, P. N., 1986, Red cell antigens P (globoside) and Luke: Identification by monoclonal antibodies defining the murine stage-specific embryonic antigens —3 and —4 (SSEA-3 and SSEA-4), Vox Sang. 51: 53–56.PubMedGoogle Scholar
  156. Tyrrell, G. J., Ramotar, K., Toye, B., Boyd, B., Lingwood, C. A., and Brunton. J. L., 1992, Alteration of the carbohydrate binding specificity of verotoxins from Galal-4Gal to Ga1NAc(31–3Galal-4Ga1 and vice versa by site-directed mutagenesis of the binding subunit, Proc. Natl. Acad. Sci. USA 89: 524–528.PubMedGoogle Scholar
  157. Ueno, K., Ando, S., and Yu, R. K., 1978, Gangliosides of human, cat, and rabbit spinal cords and cord myelin, J. Lipid Res. 19: 863–871.PubMedGoogle Scholar
  158. Ullman, M. D., and McCluer, R. H., 1978, Quantitative microanalysis of perbenzoylated neutral glycosphingolipids by high-performance liquid chromatography with detection at 230 nm, J. Lipid Res. 19: 910–913.PubMedGoogle Scholar
  159. Vance, D., and Sweeley, C. C., 1967, Quantitative determination of neutral glycosyl ceramides in human blood, J. Lipid Res. 8: 621–630.PubMedGoogle Scholar
  160. Heyningen, W. E., 1974, Gangliosides as membrane receptors for tetanus toxin, cholera toxin and serotonin, Nature 249: 415–417.Google Scholar
  161. Viitala, J., and Jämefelt, J., 1985, The red cell surface revisited, Trends Biochem. Sci. 10: 392–395.Google Scholar
  162. Voak, D., Anstee, D., and Pardoe, G., 1973, The a-galactose specificity of anti-Pk, Vox Sang. 25: 263–270.PubMedGoogle Scholar
  163. Borne, A. E. G. K.. Bos, M. J. E., Joustra-Maas, N., Tromp, J. F., van Wijngaarden-Dubois, R., and Tetteroo, P. A. T., 1986, A murine monoclonal IgM antibody specific for blood group P antigen globoside, Br. J. Haematol. 63: 35–46.Google Scholar
  164. Borne, A. E. G. K., Admiraal, L. G., Mass, L. G., van der Graaf, and Bos, M. J. E., 1987, Monoclonal antibodies against antigens of the bloodgroup P system and related structures, in Monoclonal Antibodies against Human Red Blood Cell and Related Antigens ( P. Rouger and C. Salmon, eds.), pp. 119–145, Librairie Arnette, Paris.Google Scholar
  165. Vos, G. L., Celano, M. J., Falkowski, F., and Levine. P., 1964, Relationship of a hemolysin resembling anti-Tj’ to threatened abortion in western Australia, Transfusion 4: 87–91.PubMedGoogle Scholar
  166. Watanabe, K., and Arao, Y., 1981, A new solvent system for the separation of neutral glycosphingolipids, J. Lipid Res. 22: 1020–1024.PubMedGoogle Scholar
  167. Watanabe, K., and Hakomori, S.-i., 1979, Gangliosides of human erythrocytes. A novel ganglioside with a unique N-acetylneuraminosyl-(2–3)-N-acetylgalactosamine structure, Biochemistry 18: 5502–5504.PubMedGoogle Scholar
  168. Watanabe, K., Hakomori, S.-I., Childs, R. A., and Feizi, T., 1979, Characterization of a blood group I-active ganglioside: Structural requirements for I- and i-specificities, J. Biol. Chem. 254: 3221–3228.PubMedGoogle Scholar
  169. Watkins, W. M., and Morgan, W. T. J., 1964, Blood group P, substance: (II) Immunological properties, Proc. 9th Congr. Int. Soc. Blood Transfus., Mexico 1962, pp. 230–234.Google Scholar
  170. Wiels, J., Fellous, M., and Tursz, T., 1981, Monoclonal antibody against a Burkitt lymphoma associated antigen, Proc. Natl. Acad. Sci. USA 78: 6485–6488.PubMedGoogle Scholar
  171. Wiels, J., Holmes, E. H., Cochran, N., Tursz, T., and Hakomori, S.-i., 1984, Enzymatic and organizational difference in expression of Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines, J. Biol. Chem. 259: 14783–14787.PubMedGoogle Scholar
  172. Wishart, M. M., and Davey, M. G., 1973, Infectious mononucleosis complicated with acute haemolitic anemia with positive Donath— Landsteiner reaction, J. Clin. Pathol. 26: 332–334.PubMedGoogle Scholar
  173. Worliedge, S. M.. and Rousso, C., 1965, Studies on the serology of paroxysmal cold haemoglobinuria (PCH), with special reference to its relationship with P blood group system, Vox Sang. 10: 293–298.Google Scholar
  174. Yamakawa, T., and Nagai, Y., 1978, Glycolipids at the cell surface and their biological functions, Trends Biochem. Sci. 3: 128–131.Google Scholar
  175. Yamazaki, T., Suzuki, A., Handa, S., and Yamakawa, T., 1979, Consecutive analysis of sphingoglycolipids on the basis of sugar and ceramide moieties by high performance liquid chromatography, J. Biochem. 86: 803–809.PubMedGoogle Scholar
  176. Yang, Z. T., Bergstrom, J., and Karlsson, K.-A., 1994. Glycoproteins with GalaGal are absent from human erythrocyte membranes, indicating that glycolipids are the sole carriers of blood group P activities, J. Biol. Chem. 269: 14620–14624.PubMedGoogle Scholar
  177. Yates, A. D., Morgan, W. T. J., and Watkins, W. M., 1975, Linkage-specific a- D-galactosidases from Trichomonas foetus: Characterization of the blood-group B-destroying enzyme as a 1,3-agalactosidase and the blood-group P,-destroying enzyme as a 1,4-a-galactosidase, FEBS Lett. 60: 281–285.PubMedGoogle Scholar
  178. Yoda, Y., Ishibashi, T., and Makita, A., 1980, Isolation, characterization and biosynthesis of Forssman antigen in human lung and lung carcinoma, J. Biochem. 88: 1887–1890.PubMedGoogle Scholar
  179. Yoshida, H., Ito, K., Emi, N., Kanzaki, H., and Matsuura, S., 1984, A new therapeutic antibody removal method using antigen-positive red cells II. Application to a P-incompatible pregnant woman, Vox Sang. 47: 216–223.PubMedGoogle Scholar
  180. Young, W. W., Hakomori, S., and Levine, P., 1979, Characterization of anti-Forssmann (anti-Fs) antibodies in human sera: Their specificity and possible changes in patients with cancer, J. Immunol. 123: 92–96.PubMedGoogle Scholar
  181. Zdebska, E., Anselstetter, V., Pacuszka, T., Krause, R., Chelstowska, A., Heimpel, H., and Koscielak, J., 1987, Glycolipids and glycopeptides of red cell membranes in congenital dyserythropoietic anaemia type II (CDA II), Br. J. Haematol. 66: 385–391.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Pascal Bailly
    • 1
  • Jean-François Bouhours
    • 2
  1. 1.Institut National de la Transfusion SanguineUnité de Recherche U76 de l’Institut National de la Santé et de la Recherche Médicale (INSERM)Paris Cedex 15France
  2. 2.Institut de Transplantation et de Recherche en Transplantation, Centre Hospitalier RégionalUnité de Recherche de l’Institut National de la Santé et de la Recherche Médicale (INSERM)Nantes CedexFrance

Personalised recommendations